NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cormorant Asset Management LP10% Owner2025-12-1130,029$11.46
$344.01kSell
Yuval CohenChief Executive Officer2025-10-278,973$17.14
$153.80kSell
Yuval CohenChief Executive Officer2025-10-278,973$4.26
$38.22kBuy
Yuval CohenChief Executive Officer2025-10-2418,660$17.01
$317.41kSell
Yuval CohenChief Executive Officer2025-10-2418,660$4.26
$79.49kBuy
Sean F. MoranChief Financial Officer2025-10-2412,981$4.26
$55.30kBuy
Sean F. MoranChief Financial Officer2025-10-2412,981$17.02
$220.94kSell
Anne AltmeyerDirector2025-10-201,060$4.80
$5.09kBuy
Anne AltmeyerDirector2025-10-201,060$20.50
$21.73kSell
Anne AltmeyerDirector2025-05-301,392$7.25
$10.10kSell

1 of 2

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP26.89%4,719,971$39.08MInsider
Sumner Burstein20.48%3,594,571$29.76MInsider
Knoll Capital Management LP15.67%2,750,000$22.77MInsider
Cormorant Asset Management LP13.53%2,375,000$19.67MInstitution
Mark Tepper12.02%2,110,400$17.47MInsider
Orbimed Advisors LLC6.68%1,172,287$9.71MInstitution
Octagon Capital Advisors LP6.35%1,115,000$9.23MInstitution
David P. Hochman4.66%818,700$6.78MInsider
Vanguard Group Inc3.49%612,030$5.07MInstitution
Prosight Management LP1.96%343,400$2.84MInstitution

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP37.31%62.69%Net SellingNet Selling
ELTX10.93%65.22%Net BuyingNet Buying
BDTX65.77%34.23%Net SellingNet Buying
PRLD43.21%52.21%Net Buying
MCRB3.07%96.93%Net SellingNet Selling

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 50.13% institutional shareholders, 84.25% Corbus Pharmaceuticals Holdings insiders, and 0.00% retail investors. Cormorant Asset Management LP is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 4.72M shares representing 26.89% of the company. Cormorant Asset Management LP's Corbus Pharmaceuticals Holdings shares are currently valued at $38.23M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.